logo

For the Inventor, By the Inventor

Burghausen, Germany

Michael Stepp

This inventor holds 15 USPTO granted patents, plus 1 CIPO patent. Top assignee: Wacker-Chemie Gmbh. Active years: 1993-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Stepp. Retrieved from https://idiyas.com/inventor/michael-stepp-ycfg3kqv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15

% Patents Active = 93.3


Average Co-Inventor Count = 2.8

ph-index = 7

Forward Citations = 122(Granted Patents)


Company Filing History:

goldMedal15 out of 830 
 
Wacker-Chemie Gmbh
 patents

Years Active: 1993-2006

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 6998437 - Preparation of polydiorganosiloxanes (2006-02-14),
2. 6313217 - Organosilicon compounds, processes for their preparation, and their use in crosslinkable organopolysiloxane compositions (2001-11-06),
3. 6239244 - Polysiloxane compound which is stable during storage and produces vulcanisates which can be permanently wetted with water (2001-05-29),
4. 6218498 - Organosilicon compounds having urea groups, method for producing same and their utilization (2001-04-17),
5. 6011112 - Organopolysiloxane compounds cross-linkable by cleaving of alcohols to (2000-01-04),
6. 5977243 - Organosilicon compounds, processes for their preparation, and their use (1999-11-02),
7. 5705588 - Organopolysiloxane compositions which can be crosslinked to give (1998-01-06),
8. 5670597 - Process for the preparation of organopolysiloxanes containing organyloxy (1997-09-23),
9. 5580921 - Storage-stable polysiloxane composition which gives permanently (1996-12-03),
10. 5527935 - Organopolysiloxanes having bifunctional terminal siloxane units (1996-06-18),
11. 5484871 - Organopolysiloxanes containing hydrophilic groups (1996-01-16),
12. 5434234 - Organo(poly)siloxanes, their preparation and their use (1995-07-18),
13. 5420222 - Curable organo(poly)siloxane compositions (1995-05-30),
14. 5304621 - Organo(poly)siloxanes containing terminal siloxane units having (1994-04-19),
15. 5223595 - Process for preparing organo(poly)siloxanes (1993-06-29),

Title: Michael Stepp: Innovator in Organosilicon Compounds

Introduction

Michael Stepp is a prominent inventor based in Burghausen, Germany. He has made significant contributions to the field of organosilicon chemistry, holding a total of 15 patents. His work focuses on the preparation and application of innovative organosilicon compounds.

Latest Patents

Among his latest patents is the preparation of polydiorganosiloxanes. These compounds are synthesized by reacting hexaorganocyclotrisiloxanes with alcohols, resulting in versatile materials with various applications. Another notable patent involves aliphatically unsaturated organosilicon compounds, which have 2 to 17 silicon atoms. This invention details processes for their preparation and their use in crosslinkable organopolysiloxane compositions, particularly those that can be crosslinked peroxidically or by hydrosilylation.

Career Highlights

Michael Stepp is currently employed at Wacker-Chemie GmbH, a leading company in the field of chemical production. His innovative work has positioned him as a key figure in the development of advanced materials that are essential for various industrial applications.

Collaborations

Throughout his career, Michael has collaborated with notable colleagues such as Johann Mueller and Stefan Oberneder. These partnerships have further enhanced his research and development efforts in organosilicon chemistry.

Conclusion

Michael Stepp's contributions to the field of organosilicon compounds demonstrate his expertise and innovative spirit. His patents reflect a commitment to advancing technology and materials science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…